About Foncer Pharma Private Limited
Data last updated:
Foncer Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC283986. Its GSTIN is 27AACCF8831F1ZM (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Swapnilkumar Narayan Deotalu and Parag Balkrishna Kumbalkar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 19 Flat No G1 C/O Savita Dattatray Kunte Sadguru Apartment Shashtri Layout, Nagpur, Maharashtra, India – 440022.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.73 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹87.07 Lakh (net margin 8.9%) and EBITDA of ₹92.5 Lakh (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 27% over five years.
The company has about 38 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Foncer Pharma. As per MCA filings, the company has open charges of ₹2.1 Cr and satisfied charges of ₹1.51 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website foncerpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address19 Flat No G1 C/O Savita Dattatray Kunte Sadguru Apartment Shashtri Layout, Nagpur, Maharashtra, India – 440022
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Foncer Pharma Private Limited
The main business activity of Foncer Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Foncer Pharma Private Limited FY 2024 filings available
Foncer Pharma Private Limited reported revenue of ₹9.73 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Foncer Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 21% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Foncer Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹92.5 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹87.07 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Foncer Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Foncer Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Foncer Pharma Private Limited
Foncer Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brio Bliss Life Science Private Limited | ₹9.84 Cr (FY 2021) | •••• | •••• | -35.0% | •••• | Chennai, Tamil Nadu, India |
| Kenil Healthcare Private Limited | ₹9.84 Cr (FY 2025) | •••• | •••• | 162.0% | •••• | Mehsana, Gujarat, India |
| Alps Life Sciences Private Limited | ₹9.83 Cr (FY 2022) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
| Carewin Pharmaceuticals (Gujarat) Private Limited | ₹9.77 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
| Riemann Labs Private Limited | ₹9.75 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Indore, Madhya Pradesh, India |
| Foncer Pharma Private Limited this company | ₹9.73 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Nagpur, Maharashtra, India |
| Mcneil and Argus Pharmaceuticals Limited | ₹9.73 Cr (FY 2024) | •••• | •••• | -59.0% | •••• | Haryana, India |
| Akisab Trading Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Shree Radhey Gobind International Pharmaceuticals Private Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Labinduss Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Palghat, Kerala, India |
| Renspur Health Care Private Limited | ₹9.71 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Foncer Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Foncer Pharma Private Limited
Foncer Pharma Private Limited is audited by MAB & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MAB & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Foncer Pharma Private Limited
Foncer Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parag Balkrishna Kumbalkar Also directs: Foncer Wellness Private Limited | Additional Director | 30 Apr 2019 | 7 Years 5 Months | Current |
| Swapnilkumar Narayan Deotalu Also directs: Foncer Wellness Private Limited | Director | 11 May 2018 | 8 Years 4 Months | Current |
Ownership and Shareholding of Foncer Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Foncer Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2023 | Others | ₹2.1 Cr | Open |
| 13 Mar 2023 | Others | ₹1.2 Cr | Satisfied |
| 17 Jun 2020 | Canara Bank | ₹2.95 Lakh | Satisfied |
| 11 Sep 2018 | Canara Bank | ₹28 Lakh | Satisfied |
Total charge records: 4 View all charges
Associated Brands with Foncer Pharma Private Limited
Foncer Pharma operates one associated brand: Foncer Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, procurement, and service provision in healthcare. | foncerpharma.com |
Employees and EPFO Compliance at Foncer Pharma Private Limited
Foncer Pharma Private Limited has a workforce of 38 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Foncer Pharma Private Limited
Foncer Pharma Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Savita Dattatreya Kunte ceased to be Director on 02 May 2019.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Foncer Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Foncer Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Foncer Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Foncer Pharma Private Limited
Foncer Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCF8831F1ZM | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Foncer Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Foncer Pharma Private Limited
Foncer Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 July 2016 (10+ years old) and is registered under CIN U74999MH2016PTC283986.
Foncer Pharma reported revenue of ₹9.73 Cr for FY 2025 (up 21% YoY).
Foncer Pharma has 2 current directors:
- Parag Balkrishna Kumbalkar - Additional Director
- Swapnilkumar Narayan Deotalu - Director
Foncer Pharma reported a net profit of ₹87.07 Lakh (net margin 8.9%) and EBITDA of ₹92.5 Lakh (EBITDA margin 9.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Foncer Pharma is 27% over three years and 27% over five years. In the latest year (FY 2025) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Foncer Pharma is 27AACCF8831F1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Foncer Pharma is U74999MH2016PTC283986. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Foncer Pharma was incorporated on 22 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Foncer Pharma by revenue are Brio Bliss Life Science Private Limited, Kenil Healthcare Private Limited, Alps Life Sciences Private Limited, Carewin Pharmaceuticals (Gujarat) Private Limited, Riemann Labs Private Limited and 5 more, all in the Pharma industry (Formulations).
Savita Dattatreya Kunte ceased to be Director on 02 May 2019. Parag Balkrishna Kumbalkar was appointed as Additional Director on 30 Apr 2019. Swapnilkumar Narayan Deotalu ceased to be Additional Director on 29 Sep 2018. Foncer Pharma has 5 board changes on record in total.
Foncer Pharma can be reached through the website foncerpharma.com. Its registered office is in Nagpur, Maharashtra, India.